Bazel Internatio (539946)
Asset PlayScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹49 |
| Market Cap | ₹9.65 Cr |
| P/E Ratio | 14.78 |
| ROCE | 2.3% |
| ROE | 5.54% |
| Dividend Yield | 0% |
| Profit Growth | 75% |
| Debt/Equity | — |
| Sales Growth | 57.14% |
| 52-Week Range | ₹16.5 — ₹49 |
| Sector | Finance |
| Book Value | ₹146.19 |
Strengths
- Trades at a 66% discount to book value: P/B 0.34 vs book value ₹146.19.
- Piotroski F-Score of 7/9 suggests improving financial health.
- High reported growth: sales +57.14%, profit +75%, with PEG 0.22 and P/E 14.78.
- Low absolute price gives small retail investors a chance to buy a potentially asset-backed stock at a large discount.
Concerns
- Extremely small scale: market cap ₹10 Cr, latest quarter sales ₹1 Cr and net profit ₹0 Cr.
- Weak profitability: ROE 5.54% and ROCE 2.30% indicate poor return on assets and capital.
- Critical data missing: Debt/Equity and promoter holding are N/A, creating governance and leverage uncertainty for an NBFC.
- Zero dividend yield means no income while waiting for asset value to be unlocked.
AI Analysis
At ₹49, Bazel Internatio is statistically cheap: P/B of 0.34 against book value of ₹146.19. But Benjamin Graham warned that a low price-to-book is only meaningful if the underlying assets are worth their stated value and can generate income. Here, return on equity is just 5.54% and ROCE 2.30%, so the assets are earning meager returns. A discount to book can become a value trap when capital is not being put to work profitably. The reported growth is flashy—sales up 57.14%, profit up 75%, PEG 0.22—but the base is tiny: market cap is just ₹10 crore, and the latest quarter shows sales of ₹1 crore and net profit rounded to ₹0 crore. This is not a business I can evaluate with confidence or deploy meaningful capital into. There is no meaningful moat, no scale, and no pricing power. For an NBFC, the unavailable debt/equity data and promoter holding are serious red flags. Piotroski F-Score of 7/9 is a positive, and P/E of 14.78 is not demanding if growth continues. But with ROE barely above 5%, book value will compound slowly. The zero dividend means no income while waiting. The price has already moved from ₹16.50 to ₹49, so the easy part of the rerating may be over. Until I see consistent absolute profits, stronger returns, and cleaner disclosure, I treat this as a small asset play, not a compounding machine.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer